GLP-1 Weight Loss and Diabetes Drugs Linked to Nutritional Deficiencies in Children

A new study reveals that children taking GLP-1 medications such as Victoza, Saxenda, Trulicity, and Ozempic for weight loss, prediabetes, or type 2 diabetes face a significant overlooked risk: nearly 1 in 6 young patients developed a diagnosed nutritional deficiency within one year of starting treatment. Vitamin D deficiency was the most common, affecting approximately 12% of pediatric users. These medications work by slowing gastric emptying and reducing appetite, which can impact nutrient absorption and intake. Healthcare providers should monitor children on GLP-1 therapy for nutritional deficiencies and consider supplementation strategies to prevent long-term health complications.